메뉴 건너뛰기




Volumn 50, Issue 7, 2011, Pages 1268-1274

Sensitivity and specificity of 2010 rheumatoid arthritis classification criteria

Author keywords

Classification criteria; Rheumatoid arthritis; Scoring system; Sensitivity; Specificity

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR;

EID: 79959439557     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq442     Document Type: Article
Times cited : (63)

References (20)
  • 2
    • 31044442965 scopus 로고    scopus 로고
    • The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
    • Breedveld FC, Weisman MH, Kavanaugh AF et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54:26-37.
    • (2006) Arthritis Rheum , vol.54 , pp. 26-37
    • Breedveld, F.C.1    Weisman, M.H.2    Kavanaugh, A.F.3
  • 3
    • 0034735842 scopus 로고    scopus 로고
    • for the Anti-tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis
    • Lipsky PE, van der Heijde DM, St Clair EW et al. for the Anti-tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
    • (2000) N Engl J Med , vol.343 , pp. 1594-1602
    • Lipsky, P.E.1    van der Heijde, D.M.2    St Clair, E.W.3
  • 4
    • 10744223002 scopus 로고    scopus 로고
    • TEMPO (trial of etanercept and methotrexate with radiographic patient outcomes) study investigators Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
    • Klareskog L, van der Heijde D, de Jager JP et al. TEMPO (trial of etanercept and methotrexate with radiographic patient outcomes) study investigators. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675-81.
    • (2004) Lancet , vol.363 , pp. 675-681
    • Klareskog, L.1    van der Heijde, D.2    de Jager, J.P.3
  • 5
    • 40749152243 scopus 로고    scopus 로고
    • Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
    • Yokota S, Imagawa T, Mori M et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 008;371:998-1006.
    • (2008) Lancet , vol.371 , pp. 998-1006
    • Yokota, S.1    Imagawa, T.2    Mori, M.3
  • 6
    • 77953694972 scopus 로고    scopus 로고
    • Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
    • Nam JL, Winthrop KL, van Vollenhoven RF et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis 2010;69:976-86.
    • (2010) Ann Rheum Dis , vol.69 , pp. 976-986
    • Nam, J.L.1    Winthrop, K.L.2    van Vollenhoven, R.F.3
  • 7
    • 77953696525 scopus 로고    scopus 로고
    • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
    • Smolen JS, LandewéR, Breedveld FC et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 010;69:964-75.
    • (2010) Ann Rheum Dis , vol.69 , pp. 964-975
    • Smolen, J.S.1    Landewé, R.2    Breedveld, F.C.3
  • 8
    • 0023945481 scopus 로고
    • The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
    • Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
    • (1988) Arthritis Rheum , vol.31 , pp. 315-324
    • Arnett, F.C.1    Edworthy, S.M.2    Bloch, D.A.3
  • 9
    • 0031773009 scopus 로고    scopus 로고
    • The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association
    • Harrison BJ, Symmons DP, Barrett EM et al. The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association. J Rheumatol 1998;25:2324-30.
    • (1998) J Rheumatol , vol.25 , pp. 2324-2330
    • Harrison, B.J.1    Symmons, D.P.2    Barrett, E.M.3
  • 10
    • 0033834131 scopus 로고    scopus 로고
    • Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature II. Outcome at three years
    • Harrison B, Symmons D. Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years. Rheumatology 2000;39:939-49.
    • (2000) Rheumatology , vol.39 , pp. 939-949
    • Harrison, B.1    Symmons, D.2
  • 11
    • 77956036473 scopus 로고    scopus 로고
    • rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
    • Aletaha D, Neogi T, Silman AJ et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 010;69:1580-8.
    • (2010) Ann Rheum Dis , vol.69 , pp. 1580-1588
    • Aletaha, D.1    Neogi, T.2    Silman, A.J.3
  • 12
    • 77956051855 scopus 로고    scopus 로고
    • The 2010 American College of Rheumatology/European League against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I
    • Funovits J, Aletaha D, Bykerk V et al. The 2010 American College of Rheumatology/European League against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I. Ann Rheum Dis 010;69: 1589-95.
    • (2010) Ann Rheum Dis , vol.69 , pp. 1589-1595
    • Funovits, J.1    Aletaha, D.2    Bykerk, V.3
  • 13
    • 77956042213 scopus 로고    scopus 로고
    • The 2010 American College of Rheumatology/European League against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report
    • Neogi T, Aletaha D, Silman AJ et al. The 2010 American College of Rheumatology/European League against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum 010;62: 2582-91.
    • (2010) Arthritis Rheum , vol.62 , pp. 2582-2591
    • Neogi, T.1    Aletaha, D.2    Silman, A.J.3
  • 14
    • 0037230516 scopus 로고    scopus 로고
    • Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy
    • Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 003;49:1-6.
    • (2003) Clin Chem , vol.49 , pp. 1-6
    • Bossuyt, P.M.1    Reitsma, J.B.2    Bruns, D.E.3
  • 15
    • 0031682097 scopus 로고    scopus 로고
    • Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression
    • Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum 1998;41:1571-82.
    • (1998) Arthritis Rheum , vol.41 , pp. 1571-1582
    • Wolfe, F.1    Sharp, J.T.2
  • 16
    • 0029091107 scopus 로고    scopus 로고
    • Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification)
    • van der Heijde DM, van Leeuwen MA, van Riel PL, van de Putte LB. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol 2005;22: 1792-6.
    • (2005) J Rheumatol , vol.22 , pp. 1792-1796
    • van der Heijde, D.M.1    van Leeuwen, M.A.2    van Riel, P.L.3    van de Putte, L.B.4
  • 17
    • 0038681584 scopus 로고    scopus 로고
    • Utrecht Arthritis Cohort Study Group. Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year
    • Verstappen SM, Jacobs JW, Bijlsma JW et al. Utrecht Arthritis Cohort Study Group. Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year. Arthritis Rheum 2003;48:1797-807.
    • (2003) Arthritis Rheum , vol.48 , pp. 1797-1807
    • Verstappen, S.M.1    Jacobs, J.W.2    Bijlsma, J.W.3
  • 18
    • 78650773793 scopus 로고    scopus 로고
    • Classification of rheumatoid arthritis - comparison of the 1987 ACR and 2010 ACR/EULAR criteria
    • Advance Access published October 21, doi:10 1002/art. 30100
    • van der Linden MP, Knevel R, Huizinga TW et al. Classification of rheumatoid arthritis - comparison of the 1987 ACR and 2010 ACR/EULAR criteria. Arthritis Rheum. Advance Access published October 21, 2010, doi:10.1002/art.30100.
    • (2010) Arthritis Rheum
    • van der Linden, M.P.1    Knevel, R.2    Huizinga, T.W.3
  • 19
    • 85029293926 scopus 로고    scopus 로고
    • An evaluation of the strengths and weaknesses of a register of newly diagnosed rheumatoid arthritis, 1986-2010
    • Advance Access published October 7
    • Young A, Dixey J, Williams P et al. An evaluation of the strengths and weaknesses of a register of newly diagnosed rheumatoid arthritis, 1986-2010. Rheumatology. Advance Access published October 7, 2010.
    • (2010) Rheumatology
    • Young, A.1    Dixey, J.2    Williams, P.3
  • 20
    • 78650672830 scopus 로고    scopus 로고
    • Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
    • Advance Access published August 19, doi: 10.1136/ard.2010.130625
    • Machado P, Castrejon I, Katchamart W et al. Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis. Advance Access published August 19, 2010, doi: 10.1136/ard.2010.130625.
    • (2010) Ann Rheum Dis
    • Machado, P.1    Castrejon, I.2    Katchamart, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.